Category: Boston

East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More

It was marathon Monday this week in Boston, but East Coast biotech executives were running around all week. There was a big cancer meeting in Philadelphia, a neurology shindig in Washington DC, and a liver conference that just kicked off in Europe. And the usual spate of financings and deals for a bunch of local … Continue reading “East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More”

VirZOOM Receives $1,800,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d63ff456-fbc7-4fe3-a979-429efe788874 Date 4/24/2015 Company Name VirZOOM Mailing Address 56 JFK Street Cambridge, MA 02138 USA Company Description VirZOOM, Inc. is a Cambridge, Massachusetts based start-up that develops unique active VR applications. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,800,000 Transaction Round Undisclosed Proceeds Purposes The cash will finance the commercialization phase … Continue reading “VirZOOM Receives $1,800,000 New Funding Round”

Interactive Brokers Group Acquires Covestor for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa4e9080-008c-4a6d-935e-5366a61573e1 Date 4/24/2015 Company Name Covestor Mailing Address 175 Federal St. Boston, MA 02110 USA Company Description Covestor is a real-trade sharing service for proven self-investors, a place to share your real investment decisions, gain recognition and earn fees by helping others and where all data is private, normalized and anonymous, and … Continue reading “Interactive Brokers Group Acquires Covestor for Undisclosed Sum”

Aerie Craters As Glaucoma Drug Comes up Short in Phase 3

Aerie Pharmaceuticals revealed this afternoon the first results from a group of late-stage trials for its glaucoma drug, and unfortunately for the Bedminster, NJ-based company, they don’t look pretty. The drug, known as Rhopressa, failed the primary goal of Aerie’s (NASDAQ: [[ticker:AERI]]) study. It didn’t do a better job of lowering intra-ocular pressure than timolol, … Continue reading “Aerie Craters As Glaucoma Drug Comes up Short in Phase 3”

Mobile Marketer Swirl Networks Raises $18M as Ad Beacons Beckon

Hilmi Ozguc, founder and CEO of Swirl Networks, has thought for years that wireless devices that push ads to shoppers’ smartphones while they shopped are the future of marketing and retail. Now, some of the most influential names in digital marketing and media seem to agree—including Twitter. Swirl, which is based in Boston, announced Thursday it … Continue reading “Mobile Marketer Swirl Networks Raises $18M as Ad Beacons Beckon”

Boston Angels Invest in Anti-Unicorn Apparel Company, Blank Label

Sick of those “unicorn” tech companies getting all the press? Well, Blank Label isn’t one of them. And that’s just fine with founder and CEO Fan Bi and his investors. Blank Label, which sells men’s clothing online and offline, has closed its first outside funding round: $1.1 million from a who’s who of young Boston-area … Continue reading “Boston Angels Invest in Anti-Unicorn Apparel Company, Blank Label”

Thought Industries Rides Edtech Wave, Merges Learning and E-Commerce

Online education is rapidly seeping into other, larger business sectors. LinkedIn’s $1.5 billion acquisition of Lynda.com is a leading example of edtech merging with professional networking and services. Earlier this month in Boston, textbook retailer and educational finance company Valore acquired Boundless, a maker of digital learning materials for college courses. Meanwhile, big publishers like … Continue reading “Thought Industries Rides Edtech Wave, Merges Learning and E-Commerce”

Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology

There’s an immuno-oncology frenzy going on in biotech, but with a lot of attention comes competition. Plenty of companies will be left out when all is said and done. That’s why Cambridge, MA-based Jounce Therapeutics is trying to think a step ahead, and find some places in the field that aren’t as crowded as of … Continue reading “Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology”

Doctors’ Views on Connected Health Depend on How Old They Are

Two-thirds of U.S. doctors age 40 and under believe a fully connected healthcare environment will be achieved within the next five years. For those over 40, though, the proportion falls to 39 percent—and they just might be laughing at the younger generation’s naiveté. That’s one of my takeaways from a new study by MedData Group, … Continue reading “Doctors’ Views on Connected Health Depend on How Old They Are”

Innovation Grants and Unsung Life Sciences Startups of San Diego

It comes as no surprise that federal grants for innovative research or technology transfer have become a lifeline for many early stage life sciences startups in the San Diego area. What may be surprising, though, is the extent of such funding, and the number of local biotech and medical device companies that have gotten Small … Continue reading “Innovation Grants and Unsung Life Sciences Startups of San Diego”

NorthPage Lands $6,704,998 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b850f186-b161-4a29-8175-0672597fdae7 Date 4/23/2015 Company Name NorthPage Mailing Address 555 Heritage Rd. Southbury, CT 06488 USA Company Description NorthPage helps enterprise marketing organizations to rapidly increase their digital marketing effectiveness. The cloud-based NorthPage Digital Marketing Optimization Platform enables frictionless performance benchmarking, competitive analysis and best-practice guidance. Website http://www.northpage.com Transaction Type Venture Equity Transaction … Continue reading “NorthPage Lands $6,704,998 New Funding”

Jounce Therapeutics Secures $56,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd45100d-23d8-408a-bac9-6634621330cc Date 4/23/2015 Company Name Jounce Therapeutics Mailing Address 1030 Massachusetts Avenue Cambridge, MA 02138 USA Company Description Jounce Therapeutics is focused on the discovery and development of first-in-class cancer immunotherapies designed to work not by treating a patient’s tumor directly, but instead by harnessing the patient’s immune system to seek out … Continue reading “Jounce Therapeutics Secures $56,000,000 Series B Funding”

Swirl Networks Secures $18,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=18cba9b8-db8a-45c1-b781-fa877a95ec1d Date 4/23/2015 Company Name Swirl Networks Mailing Address 420 Boylston Street 3rd Floor Boston, MA 02116 USA Company Description We build products that connect people around their passions in a simple, beautiful and useful way. Website http://www.swirl.com Transaction Type Venture Equity Transaction Amount $18,000,000 Transaction Round Undisclosed Proceeds Purposes The new … Continue reading “Swirl Networks Secures $18,000,000 New Funding”

Napa Summit 2015: Request Your Invite to Xconomy’s Most Elite Event

What are the forces shaping our innovation future—and who are the leaders who will build it? We can’t promise all the answers, but we can promise an unusually intimate and inspiring discussion of such questions at Xconomy’s most unique and exclusive event. It’s called the Napa Summit: The Xconomy Retreat on Technology, Jobs, and Growth—and … Continue reading “Napa Summit 2015: Request Your Invite to Xconomy’s Most Elite Event”

MIT Media Lab’s Joi Ito on the Future of Design, Learning & Science

Joi Ito was named director of the famous MIT Media Lab in 2011. He was not your run of the mill choice. Largely self-taught computer scientist. Former chairman of Creative Commons and a strong open source advocate. Disc jockey, nightclub entrepreneur, tech investor (Kickstarter and Twitter are among the deals he took part in). Two-time … Continue reading “MIT Media Lab’s Joi Ito on the Future of Design, Learning & Science”

Database Booster Deep Information Grabs $8M For Boston Move

If there’s a capital for database companies, it’s Boston. The city is home to dozens of businesses working in the sector, from those helping customers analyze and make predictions from their own business data (consider RapidMiner) to the various operations seeking to improve transactional database systems (such as ScaleBase and VoltDB). Now add one more … Continue reading “Database Booster Deep Information Grabs $8M For Boston Move”

Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push

Alzheimer’s disease is a minefield for drug developers. Despite billions of dollars invested by biotechs and pharmaceutical companies, a number of programs have blown up in clinical testing over the past decade. Can a star CEO march the rechristened Forum Pharmaceuticals through that treacherous terrain? Since July 2013, Forum has been helmed by Deborah Dunsire, … Continue reading “Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push”

Deep Information Sciences Garners $8,000,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3b52bc9e-557f-4164-8954-0f9587c9c0be Date 4/22/2015 Company Name Deep Information Sciences Mailing Address 1 Marina Park Drive Boston, MA 02210 USA Company Description Deep Information Sciences offers the first plug-and-play solution that leverages machine learning to evolve MySQL databases and infrastructure for the new economy’s Big Data needs. Deep’s solution allows databases to adapt to … Continue reading “Deep Information Sciences Garners $8,000,000 Series A Funding”

Tal Medical Obtains $14,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69dabf08-8da4-4310-8230-3f2819a3033e Date 4/22/2015 Company Name Tal Medical Mailing Address 500 Boylston Street Boston, MA 02116 USA Company Description Tal Medical is a clinical stage medical device company developing an innovative, neurostimulation based treatment for psychiatric disorders. Our ultimate goal and vision is to redefine the clinical paradigm in psychiatry, in a similar … Continue reading “Tal Medical Obtains $14,000,000 Series B Funding Round”

SciFluor Life Sciences Obtains $30,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a0841378-c8e4-4b6e-8401-5a02d9572c53 Date 4/22/2015 Company Name SciFluor Life Sciences Mailing Address 300 Technology Square Cambridge, MA 02139 USA Company Description The company’s late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor’s technology enables end-stage or any-stage fluorination of a wide variety of organic compounds. Our technology and our library of fluorinated analogs … Continue reading “SciFluor Life Sciences Obtains $30,000,000 New Round”

ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer

Immuno-oncology is all the rage these days, and it’s easy to see why. Breakthroughs in harnessing the power of our body’s natural defenses are unlocking new ways to fight cancer, and producing some of the most promising results the field has seen to date. But it’s not as if someone has magically cracked the code … Continue reading “ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer”

Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers

The race is on to be the first to market with a gene therapy for hemophilia. And one of the entrants just got a big round of funding in what looks like a prelude to an initial public offering. Cambridge, MA-based Dimension Therapeutics has raised a $65 million Series B round from a group of … Continue reading “Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers”

Intel, Edico Genome Working to Speed Analysis of Genomic Data

As some 3,000 experts in genomics and bioinformatics gather in Boston this morning for the opening of the 2015 Bio-IT World Conference & Expo, San Diego’s Edico Genome announced it has forged a partnership with Intel to accelerate data analysis of next-generation genome sequencing technologies. Edico Genome was founded two years ago to address a bottleneck … Continue reading “Intel, Edico Genome Working to Speed Analysis of Genomic Data”

With Fresh $14M, Tal Seeks Answers About Magnetic Depression Relief

The first antidepressant drugs were discovered by happenstance in the 1950s when experimental tuberculosis treatments unexpectedly brightened patients’ moods. Happy accidents have happened in the medical device field, too, and Tal Medical of Boston has reeled in $14 million in Series B funding to push one forward. Tal is developing a treatment for severe depression … Continue reading “With Fresh $14M, Tal Seeks Answers About Magnetic Depression Relief”

Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study

Alnylam Pharmaceuticals been saying for a few years now that its lead RNA interference drug can reduce the levels of a protein responsible for a rare, crippling nerve condition known as familial amyoidotic neuropathy, or FAP. But knocking down, or “silencing” genes that create harmful proteins isn’t enough to prove that a drug works. In … Continue reading “Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study”

Dimension Therapeutics Receives $65,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e457fe9f-80f8-4ab4-833b-3247b45da384 Date 4/21/2015 Company Name Dimension Therapeutics Mailing Address 840 Memorial Drive 4th Floor Cambridge, MA 02139 USA Company Description Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. The company was launched in 2013 by Fidelity Biosciences and REGENX Biosciences. Dimension has now raised $30M … Continue reading “Dimension Therapeutics Receives $65,000,000 Series B Funding Round”

Impinj Sells 10 Billion Chips, Unlocking Internet of Everyday Things

The real promise of the Internet of Things is connecting not just powered electronic devices, but the countless other everyday items that until recently have remained stubbornly isolated in the physical world. Impinj, a 15-year-old Seattle company, is doing just that with its radio frequency identification (RFID) technology—long in development and now finally achieving large-scale … Continue reading “Impinj Sells 10 Billion Chips, Unlocking Internet of Everyday Things”

Milestones of Innovation 5: Stephanie Kwolek and Kevlar

Let’s hear it for Stephanie Kwolek, a determined, observant, and playful chemist who died last year at the age of 90. She is the inventor-heroine of an artificial fiber stronger than steel called kevlar, which has saved thousands of soldiers and policemen from fatal bullet wounds and is used in everything from cellphones to skis. … Continue reading “Milestones of Innovation 5: Stephanie Kwolek and Kevlar”

Websense Sold to Raytheon for $1.9B, Fulfilling Vista Equity’s Plan

After more than a month of rumors that Austin, TX-based Websense and its private equity owners were looking for a buyer, Boston-area defense contractor Raytheon announced today it is acquiring the cybersecurity company in a $1.9 billion cash and debt deal. Raytheon offers customers, mostly governments and their militaries, products such as missile defense systems, … Continue reading “Websense Sold to Raytheon for $1.9B, Fulfilling Vista Equity’s Plan”

Edtech Companies Hail New Rival LinkedIn As Industry Catalyst

Are online education companies biting their nails now that their competitor Lynda.com is about to become part of Mountain View, CA-based LinkedIn, the dominant social media network for professionals? The big public company, with more than $2 billion in annual revenues, has a new mission to steer its members toward Lynda.com skills classes that might … Continue reading “Edtech Companies Hail New Rival LinkedIn As Industry Catalyst”

Recorded Future Receives $12,000,000 Series D Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=62cd4dd0-95cc-420d-95a5-941a33029170 Date 4/20/2015 Company Name Recorded Future Mailing Address 1430 Massachusetts Ave Cambridge, MA 02138 USA Company Description Recorded Future’s linguistics and statistics algorithms extract time-related information and through temporal reasoning helps users understand relationships between entities and events over time, to form the world’s first temporal analytics engine. Website http://www.recordedfuture.com Transaction … Continue reading “Recorded Future Receives $12,000,000 Series D Financing”

Innovation Hub: Which Companies Care About the Environment?

Transforming big businesses into green businesses might seem like a thorny process. But older, established companies like Ford have the potential to ignite a new generation of environmentally friendly products, according to Andrew Winston, author of The Big Pivot. By shifting their manufacturing process—like substituting aluminum for steel, as Ford has done—such companies are able … Continue reading “Innovation Hub: Which Companies Care About the Environment?”

Cuban, Corcoran Invest in Haystagg to Boost Ad Targeting

In the highly competitive world of online advertising, every bit of information counts if it can lead to a better-targeted ad. Haystagg, a Boston-based company that tries to boost the performance of digital ads for advertisers and agencies, announced it has received $600,000 in funding from Mark Cuban, the billionaire investor and owner of the … Continue reading “Cuban, Corcoran Invest in Haystagg to Boost Ad Targeting”

Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups

It’s been a transition year for Atlas Venture. Last October, the Cambridge, MA-based firm announced its tech and biotech teams would part ways and raise their own funds. The biotech group, which kept the Atlas name, has just settled into its new digs in the heart of Kendall Square, Cambridge’s biotech epicenter. It is also … Continue reading “Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups”

Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals

A new MoneyTree Report being released today shows that U.S. venture capital activity eased off during the first three months of 2015. Yet it still marked the fifth consecutive quarter in which U.S. venture funding remained above $10 billion. VCs invested $13.4 billion in 1,020 deals throughout the U.S. during the first quarter of 2015, … Continue reading “Dip, But No Slowdown in First-Quarter VC Funding, & Top 10 Deals”

meQuilibrium Obtains $9,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a865a61-4f0a-49eb-8468-1c83a8f1c8b3 Date 4/17/2015 Company Name meQuilibrium Mailing Address One Gateway Center Newton, MA 02458 USA Company Description The meQuilibrium program was created to change how you think about yourself and your challenges. Your individual meQ score reflects the way you’re holding up – mentally, emotionally, physically, with your friends and family, with … Continue reading “meQuilibrium Obtains $9,000,000 Series B Funding Round”

Scroll Media Secures $1,600,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a08e7108-24ac-4eb6-92b9-4954e303b613 Date 4/17/2015 Company Name Scroll Media Mailing Address 4 Athens Terrace Cambridge, MA 02138 USA Company Description Scroll Media Inc. develops and operates a platform which gives newsfeeds. The company was founded in 2009. Website http://www.scroll.in Transaction Type Venture Equity Transaction Amount $1,600,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Scroll Media Secures $1,600,000 New Financing”

Rethink Robotics Obtains $13,400,000 Series D Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9e782dc-994b-4524-9326-ffe0d684d3fd Date 4/17/2015 Company Name Rethink Robotics Mailing Address 27 Wormwood St. Boston, MA 02210 USA Company Description Rethink Robotics is combining the power of computers – embodied in robots – and the extraordinary intelligence of the American workforce, to increase productivity and revitalize manufacturing. Website http://www.rethinkrobotics.com Transaction Type Venture Equity Transaction … Continue reading “Rethink Robotics Obtains $13,400,000 Series D Round”

IBM Security Opens Up Library of Malware and Threat Intelligence

Despite a career spent trying to defeat increasingly skilled and sophisticated hackers, Marc van Zadelhoff remains an optimist—at least a cautious one. Van Zadelhoff, IBM Security’s vice president of strategy, isn’t ignorant of the risks his team is dealing with. He can rattle off the number of endpoints—270 million—and security events—more than 15 billion—IBM Security … Continue reading “IBM Security Opens Up Library of Malware and Threat Intelligence”

3 Things Startups Need to Know to Move to the Cloud

Despite concerns around data security, businesses are optimistic about the cloud. In fact, software-as-a-service adoption has more than quintupled from 13 percent in 2011 to 72 percent in 2014, according to a cloud computing survey conducted by North Bridge Venture Partners and Gigaom Research. For startups, the cloud has always been a great equalizer, enabling … Continue reading “3 Things Startups Need to Know to Move to the Cloud”

Rethink Robotics Adds $13M More From Wellington, Others

More money going into a prominent robotics startup today: Boston-based Rethink Robotics has raised an additional $13.4 million led by Wellington Management Company. That brings Rethink’s Series D venture haul to an even $40 million, with GE Ventures and Goldman Sachs being the other big, recent investors in the company. Rethink Robotics has raised a … Continue reading “Rethink Robotics Adds $13M More From Wellington, Others”

Boston’s meQuilibrium Snags $9M to Cut Out Stress

MeQuilibrium, an online startup trying to help people reduce stress, has received a $9 million Series B funding round from Safeguard Scientifics and Chrysalis Ventures. Boston-based meQuilibrium sells an online and mobile coaching service that is meant to help users learn to better deal with and build resilience to stressful parts of their lives, from … Continue reading “Boston’s meQuilibrium Snags $9M to Cut Out Stress”

Diving Deeper Into Cybersecurity, Recorded Future Reels In $12M

[Updated, 5/6/15. See below] Cyber attacks are so bad for business, they have made at least one rising tech company apply its broader data-analysis software to security problems. Recorded Future got started about five years ago—originally to develop technology for helping defense and financial analysts track global events and try to predict when and where … Continue reading “Diving Deeper Into Cybersecurity, Recorded Future Reels In $12M”

Hydro-Photon Garners $3,000,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2f99f0ba-7d1d-4096-b098-15de7b9e2084 Date 4/16/2015 Company Name Hydro-Photon Mailing Address PO Box 675 Blue Hill, ME 04614 USA Company Description SteriPEN is the only portable water purifier that uses ultraviolet (UV) light to destroy waterborne microbes. Whether your source is a woodland brook or an overseas hotel tap, SteriPEN purifies clear water by destroying … Continue reading “Hydro-Photon Garners $3,000,000 New Funding”

Muzzy Lane Obtains $450,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35f787f2-2c77-4ddb-ad80-7439f622cbee Date 4/16/2015 Company Name Muzzy Lane Mailing Address 260 Merrimac St. Newburyport, MA 01950 USA Company Description Muzzy Lane creates and deploys multiplayer 3D games for Education, Corporate Training, and Healthcare. We partner with publishers to deliver highly immersive experiences to their customers that are mapped to their goals, whether that … Continue reading “Muzzy Lane Obtains $450,000 New Funding Round”

Courion Receives New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e0702b72-609a-4abc-867d-8cc688106abd Date 4/16/2015 Company Name Courion Mailing Address 1900 West Park Drive 1st Floor Westborough, MA 01581 USA Company Description Courion Corporation provides award-winning self-service identity management solutions in Identity Management Suite. manual processes for user provisioning, password management, industry and regulatory compliance, profile management and digital certificate management. Website http://www.courion.com Transaction … Continue reading “Courion Receives New Round”

Doudna, Berkeley Gain Expert’s Backing In CRISPR Patent Fight

Jennifer Doudna is urging caution in the use of genetic manipulation. But she and her colleagues are also fighting for ownership of the scientific tools that make it possible. Through Doudna’s employer, the University of California, Berkeley, the biochemist and her colleagues are forging ahead with a patent fight, bolstered with documents published Monday, over … Continue reading “Doudna, Berkeley Gain Expert’s Backing In CRISPR Patent Fight”

Harvard Startup Connects Picture Frames with Wi-Fi, Touchscreens

Let’s be honest—digital picture frames are pretty lame gifts, especially for mom and dad, let alone grandpa. But that could change if a Boston startup named Glimpse has its way. Glimpse makes Skylight, a new digital picture frame that takes advantage of touchscreens and Wi-Fi to make a frame its creators say is easy to … Continue reading “Harvard Startup Connects Picture Frames with Wi-Fi, Touchscreens”

Big Day For Biotech IPOs as Aduro More Than Doubles In Price

[Updated 4/15/15, 7:14pm. See below.] Aduro Biotech (NASDAQ: [[ticker:ADRO]]) kept the immunotherapy bulls running Wednesday after raising $119 million in its initial public offering. Berkeley, CA-based Aduro sold 7 million shares at $17 apiece, a price that has more than doubled in its first trading day on the Nasdaq, pushing past $38 in late trading. … Continue reading “Big Day For Biotech IPOs as Aduro More Than Doubles In Price”